The co-founders of Rejuvenate Bio are developing gene therapies to treat age-related diseases in human and animal health.
Author Archives: VCapital Team
What’s in Store for 2024?
Investors have a renewed focus on portfolio construction, prioritizing entry prices and sufficiently diligencing deals.
Chris Gladwin: Unlocking the Value of Data
Envisioning a world where data is not just a resource but a source of profound value, a catalyst for innovation, and a force for positive change.
A Buyer’s Market
There are a variety of terms for the typical four economic cycles that markets move in. If you have lived long enough, you’ve seen several iterations.
Hello Quantum.
A spotlight on the exciting topic of quantum computing as it relates to the latest addition to our VCapital portfolio: EeroQ Quantum Hardware.
Tyler Qualio: Investor Spotlight
“If you can make money while helping the world, it’s a win-win.”
Venture Capital is Not for Quitters
VCapital looks for entrepreneurs who innovate for the long game, the ones who can withstand the inevitable challenges of change and disruption, especially when the world feels the most turned upside down.
You just can’t retire from being great.
Dear Ken Freeman…
A 2021 Year-End Report Card
With a well-distributed national presence, VCapital’s number of investors has increased 78% in the last three years. This enables us to raise funds faster when needed to capture a share of the best deals available.
Ryan Kole is Changing the World One Concussion at a Time
Ryan Kole’s career path was anything but typical. He contemplated medicine, law, psychology, even being a sports agent. Eventually he gave in to the entrepreneurial
itch.